Shares in Lihua International (NASDAQ:LIWA) were up nearly 3% in recent pre-market trading on Monday after the electric components and equipment company said it expects year-over-year improvement of 3% to 6.6% in its non-GAAP earnings for 2014. Q4 2013 results, however, declined from last year. Sales for the quarter were $217.3 million, resulting in net…
HudBay Minerals (NYSE:HBM) announced that it has acquired 10,127,500 common shares of Panoro Minerals Ltd. at a purchase price of C$0.28 per Share for total consideration of C$2,835,700. The shares acquired by Hudbay (NYSE:HBM)were purchased over the TSX Venture Exchange pursuant to a private agreement and represent approximately 4.9% of the issued and outstanding Shares….
Pzifer(NYSE:PFE)’s stock was halted in afternoon trade following the announcement that the United States District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue patent (U.S. Patent No. RE44,048), covering methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex®. Pfizer (PFE) disagrees with the ruling and will…
Horizon Technology Finance (NASDAQ:HRZN) is lower in late trading after the company reported mixed financial results for Q4. Shares are down 0.57% at $14.02, with a 52-week range of $12.77 – $15.51. The closed-end, non-diversified management investment company reported Q4 net investment income of $0.35 per share, compared with the prior-year period’s $0.36 per share….
Comcast (NASDAQ:CMCSA) shares firm Tuesday as the company is contemplating a deal with Japanese electronics maker Sharp. Sharp would build liquid crystal display (LCD) televisions with a built-in cable channel receiver, Kyodo reported. The Japanese news agency said Sharp is trying to pursuing growth by focusing on its sluggish LCD TV operations. Comcast did not…
Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at…
